Jinlong Huang

4PUBLICATIONS
1CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epidemiology not elsewhere classifiedHaematological tumoursPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 22, 2026
Economic evaluation of the second-line regimen of liposome irinotecan (II) combined with 5-FU/LV versus placebo combined with 5-FU/LV for locally advanced or metastatic pancreatic ductal adenocarcinoma in China.

|Sep 22, 2025
Post-Marketing Safety Concerns with Efgartigimod alfa: A Pharmacovigilance Analysis Based on the Food and Drug Administration Adverse Event Reporting System Database.

Jinlong Huang, Hanyun Ye, Jingyang Lin

|Oct 17, 2024
Real-world safety profile of zanubrutinib: a disproportionality analysis based on the FAERS database.

Jiangfeng Wang, Xiaochun Zheng, Jingyang Lin

|Sep 16, 2024
Drug-Induced Gynecomastia: Data Mining and Analysis of the FDA Adverse Event Reporting System Database.

Xiuli Yang, Xiaochun Zheng, Miaomiao Zhang

Pageof 1

Frequent Collaborators

2 joint publications

Xiaochun Zheng